LIVZON PHARMA (01513) spent 8.7832 million yuan on September 24 to repurchase 250,000 shares of A shares.
Lizhu Pharmaceutical (01513) announced that the company invested 8.7832 million yuan on September 24, 2024...
LIVZON PHARMA (01513) announced that the company spent 8.7832 million yuan to repurchase 250,000 A shares on September 24, 2024. The repurchase price was between 34.95 yuan and 35.76 yuan per share.
Related Articles
Capitalonline Data Service(300846.SZ): Tianyang Hongye intends to acquire 5.02% of the company's shares.
Chongqing Qin'an M&E PLC (603758.SH) intends to purchase a 99% stake in Yeguang Electronics in cash.
S.F. Holding (06936) controlling shareholder Mingde Holdings has transferred its holdings of 200 million A shares to the securities account of the employee stock ownership plan (A shares).
Capitalonline Data Service(300846.SZ): Tianyang Hongye intends to acquire 5.02% of the company's shares.
Chongqing Qin'an M&E PLC (603758.SH) intends to purchase a 99% stake in Yeguang Electronics in cash.
S.F. Holding (06936) controlling shareholder Mingde Holdings has transferred its holdings of 200 million A shares to the securities account of the employee stock ownership plan (A shares).
RECOMMEND
Three-Year R&D Spend Drains RMB 2.4 Billion, Urgent Cash Needs Drive Maiwei Biotech Back to Hong Kong Amid Compliance Scrutiny
18/09/2025
Why Generating Profit Remains Challenging for Lidar Companies
18/09/2025
SEC Adopts Landmark Rule to Restrict Shareholder Class Actions in Bid to Revive IPO Market
18/09/2025
